Research & Education

IASLC European Webinar Series - 2015/2016 - Staging of Lung Cancer - 2015

Wednesday, October 14, 2015 - 7 p.m. CEST - Recording Available

This presentation will describe the IASLC database used for the revision of the current, 7th edition, of the TNM classification for lung cancer. The recommendations of the IASLC Staging and Prognostic Factors Committee for changes in the T, the N and the M components of the classification, and in the stage grouping will be reviewed and discussed.

Thoracic Oncology Highlights from ASCO 2015 and WCLC 2015

Monday, October 12, 2015 1 p.m. EDT / 11 a.m. MDT - Recording Available

High impact abstracts presented on the topic of lung cancer at both ASCO 2015 and WCLC 2015 will be reviewed. Dr. Waqar will focus on updates in systemic therapy, and Dr. Robinson will focus on updates in radiation therapy. Following the presentations there will be ample opportunity for the audience to submit questions/comments to the faculty and discussion via Internet chat.

IASLC European Webinar Series - 2015/2016 - WHO Classification of Tumours of the Lung

Thursday, October 8, 2015 - 6 p.m. BST - Recording Available

In this program Professor Nicholson will describe the important changes in the 2015 WHO classification of lung tumours, reflecting the numerous advances in tumour genetics and therapy over the past decade. In particular, classification of small biopsies and cytology is provided within the classification for the first time, with emphasis on integration of molecular testing. Changes to classification of other major tumour types will also be presented and discussed, in particular adenocarcinomas where there have been significant revisions since 2004.

Master Protocols - A New Paradigm for Advancing Therapeutic Options: Lung-MAP (S1400), ALCHEMIST and NCI MATCH

Thursday, October 1, 2015 at 9 p.m. EDT - Recording Available

IASLC continues the Lung Cancer Grand Round Series in 2015 with this LIVE WEBINAR featuring Dr. David R. Gandara.

Radiation Webinar - Advances in Radiation Therapy

Friday, September 25, 2015 - 6 p.m. JST / 11 a.m. CEST - Recording Available

The IASLC Education Committee is pleased to announce the second program in the 2015 series of Live Webinars presented by the Advanced Radiation Technology Committee. This subcommittee is focused on providing educational and informational programs addressing state of the art radiation therapy for lung cancer. This live program will be moderated by Francoise Mornex, MD, PhD and feature presentations by Yong Chan Ahn, MD, PhD and Yasushi Nagata, M.D., Ph.D.

IASLC European Webinar Series - 2015/2016 - Surgical Standards for Non-Small Cell Lung Cancer

September 1, 2015 - 7 p.m. CEST - Recording Available

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

EGFR TKIs: What is New?

Wednesday, August 26, 2015 at 9 p.m. EDT - Recording Available

IASLC continues the Lung Cancer Grand Round Series in 2015 with this LIVE WEBINAR featuring Dr. Lecia Sequist. In this program Dr. Sequist will review the current data about best practices for treatment of stage IV EGFR mutation-positive lung cancer.

Radiation Webinar - Stereotactic Ablative Radiotherapy

Tuesday, July 21, 2015 - 1 p.m. CEST - Recording Available

The IASLC Education Committee is pleased to announce the second program in the 2015 series of Live Webinars presented by the Advanced Radiation Technology Committee. This subcommittee is focused on providing educational and informational programs addressing state of the art radiation therapy for lung cancer. This live program will be moderated by Francoise Mornex, MD, PhD and feature presentations by Dr. David Palma and Professor Suresh Senan.

Combined Treatment - Stage III NSCLC

Monday, July 20, 2015 - 8 p.m. EDT - Recording Available

This seminar will inform participants the outcomes of concurrent chemo-radiotherapy from two phase III randomized trials, which together enrolled more than 1,100 patients. With these results, the focus is now geared towards investigational approaches that merit evaluation in future clinical trials.

IASLC European Webinar Series - 2015/2016 - Biomarkers and Personalized Medicine for Patients with Lung Cancer

Thursday, July 14, 2015 - 6 p.m. BST - Recording Available

In this session, Prof. Keith Kerr updates a webinar first presented last year, on developments in personalized medicine for patients with lung cancer, the impact that this has had, and could have in the future, for those patients, and how the pursuit of biomarkers to predict response to targeted therapy has changed lung cancer diagnostics.

Pages